{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:46:18Z","timestamp":1781498778146,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejso.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T09:47:28Z","timestamp":1501753648000},"page":"2157-2162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0425-306X","authenticated-orcid":false,"given":"L.M.","family":"van Veenendaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Madu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.T.","family":"Tesselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejso.2017.07.015_bib1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/annonc\/mdl050","article-title":"Merkel cell cancer of the skin","volume":"17","author":"Pectasides","year":"2006","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2017.07.015_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1470-2045(04)01593-1","article-title":"Merkel-cell carcinoma of the skin","volume":"5","author":"Poulsen","year":"2004","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.07.015_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CCO.0b013e32834fc9fe","article-title":"Merkel cell carcinoma: recent insights and new treatment options","volume":"24","author":"Schrama","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2017.07.015_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SLA.0b013e31822c5fc1","article-title":"Five hundred patients with Merkel cell carcinoma evaluated at a single institution","volume":"254","author":"Fields","year":"2011","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2017.07.015_bib5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.ijrobp.2010.04.061","article-title":"Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre","volume":"80","author":"Hui","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2017.07.015_bib6","series-title":"Treatment and survival of 351 patients diagnosed with Merkel cell carcinoma in 2 melanoma and neuroendocrine tumor expert-centers in The Netherlands","author":"van Veenendaal","year":"2016"},{"issue":"2","key":"10.1016\/j.ejso.2017.07.015_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijrobp.2009.02.014","article-title":"Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb\u2013a review of 60 cases","volume":"76","author":"Poulsen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ejso.2017.07.015_bib8","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2017.07.015_bib9","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1245\/s10434-011-2161-x","article-title":"Natural history of Merkel cell carcinoma following locoregional recurrence","volume":"19","author":"Grotz","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.07.015_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2005.04.042","article-title":"Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?","volume":"64","author":"Poulsen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ejso.2017.07.015_bib11","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2000.18.12.2493","article-title":"Chemotherapy in neuroendocrine\/Merkel cell carcinoma of the skin: case series and review of 204 cases","volume":"18","author":"Tai","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2017.07.015_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2006.07.9319","article-title":"Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin","volume":"25","author":"Mojica","year":"2007","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2017.07.015_bib13","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1245\/s10434-016-5293-1","article-title":"Radiation therapy is associated with\u00a0improved outcomes in Merkel cell carcinoma","volume":"23","author":"Strom","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2017.07.015_bib14","doi-asserted-by":"crossref","DOI":"10.5070\/D30FS501M4","article-title":"Merkel cell carcinoma: an unusual indication for isolated limb perfusion","volume":"14","author":"Ponte","year":"2008","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.ejso.2017.07.015_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","article-title":"Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety","volume":"15","author":"Moreno-Ramirez","year":"2010","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ejso.2017.07.015_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02656730801944930","article-title":"Current status of hyperthermic limb perfusion for in-transit melanoma","volume":"24","author":"Ross","year":"2009","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2017.07.015_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00007611-199803000-00018","article-title":"Successful treatment of in-transit metastases from Merkel's cell carcinoma with isolated hyperthermic limb perfusion","volume":"91","author":"Gupta","year":"1998","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.ejso.2017.07.015_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jso.24289","article-title":"Isolated limb perfusion in Merkel cell carcinoma offers high rate of complete response and durable local-regional control: systematic review and institutional experience","volume":"114","author":"Thiels","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2017.07.015_bib19","first-page":"357","article-title":"In-transit Merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: a case series of 12 patients","volume":"37","author":"Zeitouni","year":"2011","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg"},{"issue":"7","key":"10.1016\/j.ejso.2017.07.015_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archsurg.2011.139","article-title":"Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms","volume":"146","author":"Turaga","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2017.07.015_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archsurg.134.3.303","article-title":"Hyperthermic isolated limb perfusion with tumor necrosis factor, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities","volume":"134","author":"Olieman","year":"1999","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.ejso.2017.07.015_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jso.23558","article-title":"Isolated limb perfusion with melphalan for melanoma","volume":"109","author":"Nieweg","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2017.07.015_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.sla.0000146147.89667.ed","article-title":"One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases","volume":"240","author":"Grunhagen","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2017.07.015_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejso.2017.07.015_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.07.015_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2017.07.015_bib27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"30","key":"10.1016\/j.ejso.2017.07.015_bib28","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1200\/JCO.2011.35.6618","article-title":"Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas","volume":"29","author":"Deroose","year":"2011","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2017.07.015_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejca.2014.11.020","article-title":"Treatment modifications in tumour necrosis factor-alpha (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas","volume":"51","author":"Deroose","year":"2015","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2017.07.015_bib30","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/bjs.7621","article-title":"Long-term outcome of isolated limb perfusion with tumour necrosis factor-alpha for patients with melanoma in-transit metastases","volume":"98","author":"Deroose","year":"2011","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2017.07.015_bib31","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1245\/s10434-017-5803-9","article-title":"Isolated limb perfusion for melanoma is safe and effective in elderly patients","volume":"24","author":"Madu","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.07.015_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jso.23519","article-title":"Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion","volume":"109","author":"Steinman","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2017.07.015_bib33","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F","article-title":"Chemotherapy for patients with locally advanced metastatic Merkel cell carcinoma","volume":"85","author":"Voog","year":"1999","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2017.07.015_bib34","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.ejso.2017.07.015_bib35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/01.coc.0000135926.93116.c7","article-title":"Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases","volume":"27","author":"Eng","year":"2004","journal-title":"Am J Clin Oncol"},{"issue":"26","key":"10.1016\/j.ejso.2017.07.015_bib36","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ejso.2017.07.015_bib37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.ejso.2017.07.015_bib38","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ejca.2015.06.131","article-title":"Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline","volume":"51","author":"Lebbe","year":"2015","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317305991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317305991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:24:29Z","timestamp":1760059469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317305991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0748798317305991"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2017.07.015","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}